Human brain and platelet cyclic adenosine 3′,5′-monophosphate phosphodiesterases: Different response to drugs
- 18 August 1972
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 279 (1) , 217-220
- https://doi.org/10.1016/0304-4165(72)90258-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cyclic Adenosine Monophosphate Phosphodiesterase in Brain: Effect on AnxietyScience, 1972
- Cyclic 3′,5′-nucleotide phosphodiesterase properties of the enzyme of human blood plateletsBiochimica et Biophysica Acta (BBA) - Enzymology, 1971
- Adenosine 3′,5′-Monophosphate Phosphodiesterase: Multiple Molecular FormsScience, 1971
- Papaverine - induced inhibition of phosphodiesterase activity in various mammalian tissuesLife Sciences, 1971
- Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human plateletsBiochemical Pharmacology, 1970
- 3',5' CYCLIC ADENOSINE MONOPHOSPHATE IN DEPRESSION AND MANIAThe Lancet, 1970
- Inhibition of cyclic 3′,5′-nucleotide phosphodiesterase by phenothiazine and reserpine derivativesBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1968
- Inhibition of cyclic nucleotide phosphodiesterase by adenosine 5′-triphosphate and inorganic pyrophosphateBiochemical and Biophysical Research Communications, 1966
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965
- Adenosine 3‘,5‘-Phosphate in Biological MaterialsJournal of Biological Chemistry, 1962